|
1
|
Characteristics of hospitalizations for patients who use a structured clinical care program for children with medical complexity.
|
J Pediatr
|
2011
|
2.08
|
|
2
|
The Northwest Forest Plan: origins, components, implementation experience, and suggestions for change.
|
Conserv Biol
|
2006
|
1.25
|
|
3
|
Investigation on the possibility of biowaivers for ibuprofen.
|
J Pharm Sci
|
2011
|
1.13
|
|
4
|
Non-voltage-gated L-type Ca2+ channels in human T cells: pharmacology and molecular characterization of the major alpha pore-forming and auxiliary beta-subunits.
|
J Biol Chem
|
2004
|
1.11
|
|
5
|
The serotonin transporter (SLC6A4) is present in B-cell clones of diverse malignant origin: probing a potential anti-tumor target for psychotropics.
|
FASEB J
|
2005
|
1.07
|
|
6
|
Hepatitis C virus association with peripheral blood B lymphocytes potentiates viral infection of liver-derived hepatoma cells.
|
Blood
|
2008
|
1.05
|
|
7
|
Identification of short-acting κ-opioid receptor antagonists with anxiolytic-like activity.
|
Eur J Pharmacol
|
2011
|
1.04
|
|
8
|
Close encounters of the monoamine kind: immune cells betray their nervous disposition.
|
Immunology
|
2005
|
1.01
|
|
9
|
Selective serotonin reuptake inhibitors directly signal for apoptosis in biopsy-like Burkitt lymphoma cells.
|
Blood
|
2002
|
1.00
|
|
10
|
Constitutive activation of the CD40 pathway promotes cell transformation and neoplastic growth.
|
Oncogene
|
2005
|
0.98
|
|
11
|
Type I cytokine profiles of human naïve and memory B lymphocytes: a potential for memory cells to impact polarization.
|
Immunology
|
2006
|
0.97
|
|
12
|
5-Hydroxytryptamine drives apoptosis in biopsylike Burkitt lymphoma cells: reversal by selective serotonin reuptake inhibitors.
|
Blood
|
2002
|
0.96
|
|
13
|
Treatment of chronic lymphocytic leukemia with a hypomethylating agent induces expression of NXF2, an immunogenic cancer testis antigen.
|
Clin Cancer Res
|
2009
|
0.94
|
|
14
|
Epstein-Barr virus infection in vitro can rescue germinal center B cells with inactivated immunoglobulin genes.
|
Blood
|
2005
|
0.93
|
|
15
|
Population depletion activates autonomous CD154-dependent survival in biopsylike Burkitt lymphoma cells.
|
Blood
|
2002
|
0.92
|
|
16
|
CD4-8- dendritic cells prime CD4+ T regulatory 1 cells to suppress antitumor immunity.
|
J Immunol
|
2005
|
0.92
|
|
17
|
Multiphoton microscopy of transdermal quantum dot delivery using two photon polymerization-fabricated polymer microneedles.
|
Faraday Discuss
|
2011
|
0.92
|
|
18
|
Dopamine targets cycling B cells independent of receptors/transporter for oxidative attack: Implications for non-Hodgkin's lymphoma.
|
Proc Natl Acad Sci U S A
|
2006
|
0.90
|
|
19
|
B-lymphocyte subpopulations are equally susceptible to Epstein-Barr virus infection, irrespective of immunoglobulin isotype expression.
|
Immunology
|
2003
|
0.89
|
|
20
|
SLC6A4 expression and anti-proliferative responses to serotonin transporter ligands chlomipramine and fluoxetine in primary B-cell malignancies.
|
Leuk Res
|
2010
|
0.88
|
|
21
|
Naive and memory B cells respond differentially to T-dependent signaling but display an equal potential for differentiation toward the centroblast-restricted CD77/globotriaosylceramide phenotype.
|
Eur J Immunol
|
2003
|
0.88
|
|
22
|
An interesting case of joint prosthesis allergy.
|
Dermatitis
|
2009
|
0.88
|
|
23
|
Harnessing serotonergic and dopaminergic pathways for lymphoma therapy: evidence and aspirations.
|
Semin Cancer Biol
|
2007
|
0.87
|
|
24
|
CD40 ligation downregulates EBNA-2 and LMP-1 expression in EBV-transformed lymphoblastoid cell lines.
|
Int J Cancer
|
2002
|
0.87
|
|
25
|
A non-voltage-gated calcium channel with L-type characteristics activated by B cell receptor ligation.
|
Biochem Pharmacol
|
2003
|
0.87
|
|
26
|
Statistical approaches to indirectly compare bioequivalence between generics: a comparison of methodologies employing artemether/lumefantrine 20/120 mg tablets as prequalified by WHO.
|
Eur J Clin Pharmacol
|
2012
|
0.87
|
|
27
|
The effects of malignant transformation on susceptibility of human urothelial cells to CD40-mediated apoptosis.
|
J Natl Cancer Inst
|
2002
|
0.85
|
|
28
|
Discovery of 8-azabicyclo[3.2.1]octan-3-yloxy-benzamides as selective antagonists of the kappa opioid receptor. Part 1.
|
Bioorg Med Chem Lett
|
2010
|
0.84
|
|
29
|
CD154 tone sets the signaling pathways and transcriptome generated in model CD40-pluricompetent L3055 Burkitt's lymphoma cells.
|
J Immunol
|
2007
|
0.82
|
|
30
|
Characterisation of the endogenous human peripheral serotonin transporter SLC6A4 reveals surface expression without N-glycosylation.
|
J Neuroimmunol
|
2008
|
0.81
|
|
31
|
Systematic review of respiratory health among dairy workers.
|
J Agromedicine
|
2013
|
0.81
|
|
32
|
Bioequivalence requirements in the European Union: critical discussion.
|
AAPS J
|
2012
|
0.81
|
|
33
|
SB225002 promotes mitotic catastrophe in chemo-sensitive and -resistant ovarian cancer cells independent of p53 status in vitro.
|
PLoS One
|
2013
|
0.81
|
|
34
|
Flexible services for the support of research.
|
Philos Trans A Math Phys Eng Sci
|
2012
|
0.81
|
|
35
|
Evidence for functional trace amine associated receptor-1 in normal and malignant B cells.
|
Leuk Res
|
2011
|
0.81
|
|
36
|
Lymphoma cells protected from apoptosis by dysregulated bcl-2 continue to bind annexin V in response to B-cell receptor engagement: a cautionary tale.
|
Leuk Res
|
2005
|
0.80
|
|
37
|
Influence of point estimates and study power of bioequivalence studies on establishing bioequivalence between generics by adjusted indirect comparisons.
|
Eur J Clin Pharmacol
|
2015
|
0.78
|
|
38
|
Proteinase-3, a serine protease which mediates doxorubicin-induced apoptosis in the HL-60 leukemia cell line, is downregulated in its doxorubicin-resistant variant.
|
Oncogene
|
2002
|
0.78
|
|
39
|
Antigen specificity acquisition of adoptive CD4+ regulatory T cells via acquired peptide-MHC class I complexes.
|
J Immunol
|
2008
|
0.78
|
|
40
|
The human AKNA gene expresses multiple transcripts and protein isoforms as a result of alternative promoter usage, splicing, and polyadenylation.
|
DNA Cell Biol
|
2005
|
0.77
|
|
41
|
Clinically relevant biomarkers in targeted radiotherapy.
|
Clin Exp Metastasis
|
2012
|
0.77
|
|
42
|
Dynamic interplay between the neutral glycosphingolipid CD77/Gb3 and the therapeutic antibody target CD20 within the lipid bilayer of model B lymphoma cells.
|
Biochem Biophys Res Commun
|
2007
|
0.76
|
|
43
|
SAR development of a series of 8-azabicyclo[3.2.1]octan-3-yloxy-benzamides as kappa opioid receptor antagonists. Part 2.
|
Bioorg Med Chem Lett
|
2010
|
0.76
|
|
44
|
5-Chloroindole: a potent allosteric modulator of the 5-HT₃ receptor.
|
Br J Pharmacol
|
2013
|
0.76
|
|
45
|
Improved access to CD20 following B cell receptor cross-linking at Burkitt's lymphoma cell surfaces.
|
Leuk Res
|
2004
|
0.76
|
|
46
|
Community-based psychodynamic treatment program for severe personality disorders: clinical description and naturalistic evaluation.
|
J Psychiatr Pract
|
2009
|
0.76
|
|
47
|
Neuro-immuno-endocrine considerations for cancer development and therapeutics.
|
Semin Cancer Biol
|
2008
|
0.75
|
|
48
|
In response to "Selective serotonin reuptake inhibitors--a new modality for the treatment of lymphoma/leukaemia?" by C. Schuster, et al. [Biochem. Pharmacol. 74 (9) 2007 1424-1435].
|
Biochem Pharmacol
|
2008
|
0.75
|
|
49
|
A novel assay platform for the detection of translation modulators of spermidine/spermine acetyltransferase.
|
Curr Pharm Des
|
2014
|
0.75
|
|
50
|
Enhancing the anti-lymphoma potential of 3,4-methylenedioxymethamphetamine ('ecstasy') through iterative chemical redesign: mechanisms and pathways to cell death.
|
Invest New Drugs
|
2011
|
0.75
|
|
51
|
The rhythm of survival.
|
JEMS
|
2010
|
0.75
|
|
52
|
New disc-based technologies for diagnostic and research applications.
|
Psychiatr Genet
|
2002
|
0.75
|